TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34530059

Group type: EXPERIMENTAL
Intervention: SDF (Silver Diamine Fluoride)
Number of subjects: 80

Group type: COMPARATOR
Intervention: ART (Alternative Restorative Treatment)
Number of subjects: 80
Study: 34193435

Group type: EXPERIMENTAL
Intervention: Palliative care (PC) service coverage
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Referral to PC service
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Inpatient PC duration
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Referral to outpatient service
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: PC coverage variation
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Predictors of lower PC coverage
Number of subjects: 2800
Study: 32701720

Group type: EXPERIMENTAL
Intervention: PSMA PET/CT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid PET/MRI
Number of subjects: 0
Study: 35151305

Group type: EXPERIMENTAL
Intervention: Working Out Dads (WOD) peer support group intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Usual care (30-min mental health and service focused phone consultation with a health professional)
Number of subjects: 280
Study: 34248187

Group type: EXPERIMENTAL
Intervention: Saline injection (10 ml of normal saline) prior to interscalene block
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional group (no saline injection)
Number of subjects: 36
Study: 32697978

Group type: EXPERIMENTAL
Intervention: Elongation Index (EI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Deformation Index (DI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Numerical simulation of mDC experiment
Number of subjects: 0
Study: 34051886

Group type: EXPERIMENTAL
Intervention: Same-day screening with Ag-RDT, use of facial masks, and adequate air ventilation during a 5-hour indoor concert.
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Control group (no attendance at the event).
Number of subjects: 1047
Study: 32054791

Group type: EXPERIMENTAL
Intervention: Bladder Training (BT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conservative Advice (CA)
Number of subjects: 38
Study: 35965627

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 600

Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 600

Group type: COMPARATOR
Intervention: SBK
Number of subjects: 600
Study: 34281485

Group type: EXPERIMENTAL
Intervention: Telephone-based peer support intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 108
Study: 34893356

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial in community health worker recruitment
Number of subjects: 0
Study: 32289479

Group type: EXPERIMENTAL
Intervention: 8 g/day valacyclovir
Number of subjects: 88
Study: 33563623

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 32440936

Group type: EXPERIMENTAL
Intervention: Extended coronally advanced flap (ECAF) associated with acellular dermal matrix graft (ADMG)
Number of subjects: 17
Study: 33722999

Group type: EXPERIMENTAL
Intervention: Bromhexine 8 mg four times a day in addition to standard therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard treatment (lopinavir/ritonavir and interferon beta-1a)
Number of subjects: 100
Study: 33309354

Group type: EXPERIMENTAL
Intervention: 0% GH, 24% SBH (0GH)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 8% GH, 16% SBH (8GH)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 16% GH, 8% SBH (16GH)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 24% GH, 0% SBH (24GH)
Number of subjects: 16
Study: 32535138

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) recovery protocol: five repetitions of 40 s separated by 20 s of rest on calf, quadriceps, hamstrings, and gluteus muscles 5 min after each match.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Passive Recovery (PR)
Number of subjects: 16
Study: 35255973

Group type: EXPERIMENTAL
Intervention: Aloe arborescens fomentation applied after breastfeeding six times per day for 5 days.
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (control group).
Number of subjects: 60
Study: 34766835

Group type: EXPERIMENTAL
Intervention: Personal environmental chemical results report
Number of subjects: 295

Group type: COMPARATOR
Intervention: Only study-wide (aggregate) findings report
Number of subjects: 295
Study: 35196591

Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac eye drops thrice daily for 2 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: 0.09% bromfenac eye drops twice daily for 2 weeks
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac eye drops
Number of subjects: 160

Group type: COMPARATOR
Intervention: 0.09% bromfenac eye drops
Number of subjects: 160
Study: 34295852

Group type: EXPERIMENTAL
Intervention: Goleghand®
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 60
Study: 35288148

Group type: EXPERIMENTAL
Intervention: 1-L PEG with low-dose ASC (50% lower ASC concentration)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: 1-L PEG with low-dose ASC (25% lower ASC concentration)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: 1-L PEG with low-dose ASC
Number of subjects: 215
Study: 33784030

Group type: EXPERIMENTAL
Intervention: Verum TBS (theta burst stimulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham TBS
Number of subjects: 0
Study: 32382172

Group type: EXPERIMENTAL
Intervention: Brief psychosocial intervention (BPI)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Nonspecific control intervention
Number of subjects: 66
Study: 35144649

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) at a dose of 3 g/day containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Perilla Oil (PO) at a dose of 3 g/day containing α-linolenic acid (ALA)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Linseed and Fish Oil (LFO) at a dose of 3 g/day containing EPA, DHA, and ALA
Number of subjects: 150
Study: 34204498

Group type: EXPERIMENTAL
Intervention: BTE-HE (biphasic truncated exponential high-energy) defibrillator, fixed-energy protocol 200–200–200 J
Number of subjects: 78

Group type: COMPARATOR
Intervention: PB (pulsed biphasic) defibrillator, fixed-energy protocol 200–200–200 J
Number of subjects: 78
Study: 35761557

Group type: EXPERIMENTAL
Intervention: Cellular chickpea-flour with preserved cellular integrity
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional raw-milled chickpea-flour
Number of subjects: 22
Study: 33564126

Group type: EXPERIMENTAL
Intervention: Preterm formula (PTF)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Crossover group (PTF until 40 weeks CGA, then term formula (TF) until 6 months)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Faster weight gain from term to 12 weeks CGA
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Infant head growth
Number of subjects: 92
Study: 32402523

Group type: EXPERIMENTAL
Intervention: Treatment Initiation Program (adherence intervention)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Treatment as Usual (control)
Number of subjects: 187
Study: 35449865

Group type: EXPERIMENTAL
Intervention: Early cognitive training combined with aerobic exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional health education combined with rehabilitation training
Number of subjects: 90
Study: 34089431

Group type: EXPERIMENTAL
Intervention: Temperature-controlled radiofrequency ablation (DT catheter)
Number of subjects: 71
Study: 34587217

Group type: EXPERIMENTAL
Intervention: BW-60:60 (body-weight exercises 10x60s with 60s rest)
Number of subjects: 27

Group type: COMPARATOR
Intervention: SM-20:10 (body-weight exercises 20x20s with 10s rest)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Ergo-60:60 (cycling 10x60s at 100%Wmax with 60s rest)
Number of subjects: 27

Group type: COMPARATOR
Intervention: SM-40:20 (body-weight exercises 15x40s with 20s rest)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: BW-60:60
Number of subjects: 27

Group type: COMPARATOR
Intervention: Ergo-60:60 and BW-60:60
Number of subjects: 27
Study: 35281480

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral transversus thoracic muscle plane block
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 70
Study: 32238091

Group type: EXPERIMENTAL
Intervention: MF therapy combined with chemotherapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham MF therapy combined with chemotherapy
Number of subjects: 77
Study: 35263841

Group type: EXPERIMENTAL
Intervention: Granisetron transdermal system (GTS)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 389
Study: 33528751

Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis (IA)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Extracorporeal anastomosis (EA)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intracorporeal end‐to‐end anastomosis (IEEA)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Intracorporeal side‐to‐side anastomosis (ISSA)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: SF‐36 ver.2
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: EORTC QLQ‐C30 ver.3
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: SURG‐TLX
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 5‐year disease‐free survival
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 300
Study: 33631763

Group type: EXPERIMENTAL
Intervention: Laser haemorrhoidoplasty (LAH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional open haemorrhoidectomy (COH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both LAH and COH
Number of subjects: 0
Study: 33497537

Group type: EXPERIMENTAL
Intervention: Valsartan/cilnidipine (80/10 mg)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Valsartan/hydrochlorothiazide (80/12.5 mg)
Number of subjects: 129
Study: 32975088

Group type: EXPERIMENTAL
Intervention: EPF combined with CNRT
Number of subjects: 153

Group type: COMPARATOR
Intervention: DPF combined with CCRT
Number of subjects: 153
Study: 33451263

Group type: EXPERIMENTAL
Intervention: Advance Care Planning Videos
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (no videos)
Number of subjects: 241
Study: 32235144

Group type: EXPERIMENTAL
Intervention: Multimodal analgesic regimen including acetaminophen 1,000 mg, gabapentin 600 mg, ketamine 5 µg/kg/min, and lidocaine 1.5 mg/kg/h
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Multimodal analgesic regimen
Number of subjects: 299
Study: 35104665

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg, monthly intravenous for 6 months)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 6 months)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34802257

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass surgery
Number of subjects: 0
Study: 32830326

Group type: EXPERIMENTAL
Intervention: Group therapy intervention (12-week duration)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance and number of therapeutic techniques (treatment-specific predictors)
Number of subjects: 52
Study: 35371277

Group type: EXPERIMENTAL
Intervention: Intensive hand training on the basis of routine rehabilitation treatment (including inducing five finger extension, forcibly pulling fingers and wrist joints, suddenly opening fist after clenching fist)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine rehabilitation treatment (including routine joint activity training, bed training, exercise therapy, and ADL ability training)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Intensive hand training
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine rehabilitation treatment
Number of subjects: 110
Study: 34289056

Group type: EXPERIMENTAL
Intervention: DNMT3A and DNMT3A/3L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNMT3A/3L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modeling of DNMT3A/3L
Number of subjects: 0
Study: 32193729

Group type: EXPERIMENTAL
Intervention: HIV self-test kits supplied immediately (10 kits)
Number of subjects: 10

Group type: COMPARATOR
Intervention: HIV self-test kits supplied after 3 months (6 kits)
Number of subjects: 10
Study: 35820437

Group type: EXPERIMENTAL
Intervention: Small-sized MCE
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard MCE
Number of subjects: 96
Study: 33219407

Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Stress Management (PRISM)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 92
Study: 33651182

Group type: EXPERIMENTAL
Intervention: Additional group education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard preoperative counseling
Number of subjects: 0
Study: 32168780

Group type: EXPERIMENTAL
Intervention: Insoles with polypropylene (58° D Shore)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polypropylene with selective aluminium (60 HB Brinell hardness)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethylene vinyl acetate (EVA) (52° A Shore)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary EVA (25° A Shore)
Number of subjects: 0
Study: 35594274

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 142
Study: 33179388

Group type: EXPERIMENTAL
Intervention: 2-week splinting
Number of subjects: 19

Group type: COMPARATOR
Intervention: Functional splinting time
Number of subjects: 19
Study: 32887611

Group type: EXPERIMENTAL
Intervention: Finite element analysis (FEA) with quantized weight-bearing area
Number of subjects: 5

Group type: COMPARATOR
Intervention: Three different loading surfaces
Number of subjects: 5
Study: 35983677

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention (IG)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 300
Study: 32390475

Group type: EXPERIMENTAL
Intervention: MoM THA
Number of subjects: 104

Group type: COMPARATOR
Intervention: HR
Number of subjects: 104
Study: 32252674

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVA) injection followed by panretinal photocoagulation (PRP)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Early vitrectomy
Number of subjects: 34
Study: 36396064

Group type: EXPERIMENTAL
Intervention: Multicultural Healthy Diet (anti-inflammatory dietary pattern)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual diet (control)
Number of subjects: 0
Study: 34190207

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy followed by autologous stem cell transplantation (HD-ASCT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Whole brain radiation therapy (WBRT)
Number of subjects: 140
Study: 32077519

Group type: EXPERIMENTAL
Intervention: V3P-brace
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: VER-brace
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ACL-brace
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All three knee braces
Number of subjects: 24
Study: 33618016

Group type: EXPERIMENTAL
Intervention: Smokers in deprived state (overnight abstinence)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Smokers in satiated state (following smoking reinstatement)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Nonsmokers (control group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Smokers (both states)
Number of subjects: 102
Study: 34209131

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic dosing algorithm
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard-of-care dose adjustment
Number of subjects: 144
Study: 33200413

Group type: EXPERIMENTAL
Intervention: PMR (Progressive Muscle Relaxation) delivered via smartphone app
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (diary-only)
Number of subjects: 139
Study: 34419626

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 32744512

Group type: EXPERIMENTAL
Intervention: PEG‐IFN therapy
Number of subjects: 222

Group type: COMPARATOR
Intervention: PEG‐IFN monotherapy
Number of subjects: 222

Group type: COMPARATOR
Intervention: HBsAg <20,000 IU/ml
Number of subjects: 222
Study: 35457704

Group type: EXPERIMENTAL
Intervention: Slackline training (15 min per day for 5 days)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Slackline training
Number of subjects: 28
Study: 33774968

Group type: EXPERIMENTAL
Intervention: Topical application of diltiazem gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no diltiazem gel)
Number of subjects: 80
Study: 32637624

Group type: EXPERIMENTAL
Intervention: Formalizing customary land rights program
Number of subjects: 70000

Group type: COMPARATOR
Intervention: Control group (villages without the program)
Number of subjects: 70000
Study: 34774639

Group type: EXPERIMENTAL
Intervention: Sebelipase alfa
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 34957157

Group type: EXPERIMENTAL
Intervention: Qigong exercise program for 12 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 125
Study: 33183576

Group type: EXPERIMENTAL
Intervention: Curcumin 1000 mg/day for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study: 35546206

Group type: EXPERIMENTAL
Intervention: 5000 steps walking exercise
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 10,000 steps walking exercise
Number of subjects: 300

Group type: COMPARATOR
Intervention: 0 steps walking exercise
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intestinal cleansing interval (< 5.12 h)
Number of subjects: 300
Study: 33657871

Group type: EXPERIMENTAL
Intervention: Auricular intradermal acupuncture (AIA)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham AIA
Number of subjects: 49
Study: 32451203

Group type: EXPERIMENTAL
Intervention: Education group (received face-to-face information and an education booklet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (received usual care)
Number of subjects: 0
Study: 32106792

Group type: EXPERIMENTAL
Intervention: Alendronate/Vitamin D3 70 mg/5600 IU for 24 weeks (concomitant treatment arm, CTA)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Alendronate/Vitamin D3 70 mg/5600 IU starting 24 weeks after study entry (delayed treatment arm, DTA)
Number of subjects: 29

Group type: COMPARATOR
Intervention: No bone anti-resorptive therapy (standard of care, SOC)
Number of subjects: 29
Study: 35220831

Group type: EXPERIMENTAL
Intervention: BD Venflon™ I with Instaflash needle technology
Number of subjects: 1402

Group type: COMPARATOR
Intervention: BD Venflon™ without Instaflash needle technology
Number of subjects: 1402
Study: 32445738

Group type: EXPERIMENTAL
Intervention: Hybrid CSII regimen
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual CSII regimen
Number of subjects: 31
Study: 35201671

Group type: EXPERIMENTAL
Intervention: Edmonton Obesity Staging System (EOSS) scores in early pregnancy
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Edmonton Obesity Staging System (EOSS) scores in late pregnancy
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Change in EOSS scores from early to late pregnancy
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Change in EOSS scores for women moving from stage 0 to stage 2
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Relationship between early EOSS and large for gestational age
Number of subjects: 348
Study: 33677781

Group type: EXPERIMENTAL
Intervention: 6-month weight loss intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: usual care group
Number of subjects: 151
Study: 36018510

Group type: EXPERIMENTAL
Intervention: RMET (Respiratory Muscle Endurance Training)
Number of subjects: 24

Group type: COMPARATOR
Intervention: PLA (Placebo)
Number of subjects: 24
Study: 33551004

Group type: EXPERIMENTAL
Intervention: Combined chemical, mechanical, and heat cleaning
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard cleaning
Number of subjects: 32
Study: 34006150

Group type: EXPERIMENTAL
Intervention: Supine tubeless PCNL
Number of subjects: 4
Study: 33851442

Group type: EXPERIMENTAL
Intervention: Online intervention to reduce disordered eating
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 100
Study: 32017246

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Adenotonsillotomy (ATT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: All patients (ATE + ATT)
Number of subjects: 68
Study: 35696375

Group type: EXPERIMENTAL
Intervention: E-SEE Steps model (Incredible Years® parent program)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IY training and supervision for practitioners
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IY Babies book as a standalone universal component
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Targeted programs for parents with low mood
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Alignment of PU model with commissioned service contracts
Number of subjects: 29
Study: 34971192

Group type: EXPERIMENTAL
Intervention: Enhanced Physical Activity (PA) - 26-week supervised aerobic exercise program at 70-80% heart rate reserve for 50 minutes, 3 times per week
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Enhanced Physical Activity (PA)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Usual Physical Activity (PA)
Number of subjects: 23
Study: 34355408

Group type: EXPERIMENTAL
Intervention: Tele‐P cognitive behavioural intervention (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33705849

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control
Number of subjects: 142
Study: 32535917

Group type: EXPERIMENTAL
Intervention: Silicon (Si) at 2 mmol L‐1
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no Si)
Number of subjects: 4
Study: 35120306

Group type: EXPERIMENTAL
Intervention: Anti-EGFR agent
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 1607